NIH-funded research R01 grant

Dynamic risk tools to prevent blood clots and bleeding in cancer patients

Official title: Multi-modal dynamic risk prediction of thrombosis and bleeding in patients with cancer

Funded at Baylor College of Medicine · NIH-11402709 · Data updated 2026-11-12

A new AI-based approach will predict who among people with cancer starting treatment is at higher risk for blood clots or dangerous bleeding, helping doctors tailor preventive care.

More Thrombosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 22, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$677,991
NIH project number5R01HL180402-02
Project IDNIH-11402709 on NIH RePORTER

Who could benefit from this research

Could help

Adults with cancer who are starting systemic anticancer therapy and are at varying risks for thrombosis and bleeding.

Less likely to help

Patients with very low risk of clots or very high risk of bleeding may not benefit from adjusted anticoagulation strategies.

What this research studies

This project uses advanced language-model techniques and data from three US health systems to predict thrombotic and bleeding events in about 330,000 cancer patients. It will read clinical notes and other data to create a dynamic risk score that updates as patients begin or change cancer therapy. The goal is to guide personalized decisions about preventive anticoagulant therapy to reduce harm from clots while avoiding excessive bleeding. The work includes careful consideration of fairness across age, sex, race, ethnicity, and cancer type, with external validation across diverse populations.

Why it matters

Potential benefit: If successful, patients could receive more precise protection against clots with fewer bleeding complications.

How similar studies have gone: Previous studies show promise for AI-driven risk prediction, but external validation in diverse cancer populations is still needed.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Li, Ang — Baylor College of Medicine
  • Study coordinator: Li, Ang

Related research

Other NIH-funded projects on the same topics.

  • Thrombosis and Bleeding Risk in Medical Inpatients

    A patient-facing program to better predict who is at risk for blood clots or bleeding during and after hospital stays, and to tailor prevention accordingly.

    NIH research University of Vermont & St Agric College · Burlington, United States · NIH-11366383

  • How blood-contacting devices affect platelets, clots, and bleeding

    They are creating computer models to understand why heart pumps and other blood-contacting devices can make platelets trigger clots or bleeding in people who use them.

    NIH research University of Maryland Baltimore · Baltimore, United States · NIH-11238491

  • Modeling how medical devices affect blood platelets and bleeding risks

    This study is looking at how certain medical devices that come into contact with your blood can affect platelets, which are important for clotting, and it aims to find ways to make these devices safer for patients like you.

    NIH research University of Maryland Baltimore · Baltimore, United States · NIH-10986121

  • Identifying and preventing blood clots in hospitalized children

    This study is looking to find out which hospitalized kids are most likely to develop blood clots, so we can better prevent them and keep kids safe during their hospital stay.

    NIH research University of California, San Diego · La Jolla, United States · NIH-10892650

  • Role of blood flow mechanics and transfusion in sepsis-related tiny-cl vessel clots

    A patient-focused look at how red blood cell flow and transfusions might influence tiny blood vessel clots and organ problems in sepsis.

    NIH research Emory University · Atlanta, United States · NIH-11629726

  • Understanding how DVT forms and heals to prevent vein scarring

    This NIH grant supports a physician-scientist to study why deep vein clots form and how vein walls get scarred, with the goal of improving long-term outcomes for patients who develop DVT.

    NIH research Portland VA Medical Center · Portland, United States · NIH-11522579

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.